Sun, Mar 1, 2015, 2:20 AM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

eBay Inc. (EBAY) Message Board

semihound 6 posts  |  Last Activity: Feb 25, 2015 3:26 PM Member since: May 4, 2012
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Lame presentation

    by eastofeden73 Feb 25, 2015 3:09 PM
    semihound semihound Feb 25, 2015 3:26 PM Flag

    What the hell are you talking about? You have no idea of the level of medical knowledge in that audience. Handing out bullet points related to clinical aspects of obscure conditions like SHPT and simply standing up and saying that you will take questions would have been disastrous. Comparing that to a high school presentation makes me think that must be your level of actual understanding rather than a serious suggestion.

  • semihound by semihound Feb 17, 2015 2:18 PM Flag

    You're like a midget that gets knocked out in a boxing match but keeps getting up and staggering around the ring throwing punches at make believe opponents.

    I understand that you really really hate OPK and it is also clear that you get some kind satisfaction out of posting negative diatribes to get under the skin of those who are rooting for the stock.

    I can't believe that you really get enjoyment out of this endless stream of repetitive pointless babbling. Please understand it is not my intention to "retaliate" and snark back at you. If you want to continue this, that's your choice. But also understand you look incredibly foolish and small minded. If that's what you're going for, you are certainly getting it.

    As far as you short position in OPK goes, I wish you the same luck I would wish any other investor. As we all know winning at this game is a delicate blend of skill, luck and timing. Who knows you may be right. Time will tell. So perhaps you can take my sentiment to heart and try some other avenues to get the fun, or whatever it is you are seeking, in some other more constructive way.

    Sentiment: Hold

  • Reply to


    by semihound Feb 17, 2015 2:18 PM
    semihound semihound Feb 17, 2015 2:58 PM Flag

    If that's the case why did you bother to even key in a response. Is it perhaps that you yourself get some private stimulation from being the bad #$%$ dude that calls out those you deem worthy of your harsh, semi-educated, judgments. By the way, the phrase is "on deaf ears" not "death ears" but I'm sure you knew that, right Mr. Dorf?

  • Reply to

    Just do exactly the opposite #$%$,. platium

    by drofoncology Feb 24, 2015 4:01 PM
    semihound semihound Feb 24, 2015 4:15 PM Flag

    But Dorf,I thought your strategy was to pretend he didn't exist. But it appears you actually follow his as a contrarian. Maybe you need to follow your own advice and let ramblings fall on, as you put it, "death ears".

  • Reply to


    by semihound Feb 17, 2015 2:18 PM
    semihound semihound Feb 17, 2015 2:34 PM Flag


  • Reply to

    Rayaldy Sales

    by momentum_play Feb 25, 2015 11:03 AM
    semihound semihound Feb 25, 2015 1:46 PM Flag

    As a CKD Stage 3 patient I can tell you that, among both the patient and physician community, there is widespread anticipation of the Rayaldy launch. Existing treatments leave much to be desired in terms of effectiveness. For instance, I take 50K units of Vit D daily (a dose that would create Vit D toxicity in a healthy person) plus 1K mg of Calcitrol. In spite of this mega D dosing profile my Parathyroid levels are still 8 to 10 times higher than the normal range.

    So, yes, I believe that considering the global SHPT market and the many other emerging and off label uses for a form of Vit D that has the highest level of bioavailability currently available, is enormous. And remember that for patients like me the consequences of not correcting the SHPT problem are grave, if you get my meaning.

57.91-0.63(-1.08%)Feb 27 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.